Literature DB >> 20655938

Disruption of thyroid hormone homeostasis in Ugt1a-deficient Gunn rats by microsomal enzyme inducers is not due to enhanced thyroxine glucuronidation.

Terrilyn A Richardson1, Curtis D Klaassen.   

Abstract

Microsomal enzyme inducers (MEI) that increase UDP-glucuronosyltransferases (UGTs) are thought to increase glucuronidation of thyroxine (T(4)), thus reducing serum T(4), and subsequently increasing thyroid stimulating hormone (TSH). Ugt1a1 and Ugt1a6 mediate T(4) glucuronidation. Therefore, this experiment determined the involvement of Ugt1a enzymes in increased T(4) glucuronidation, decreased serum T(4), and increased TSH after MEI treatment. Male Wistar and Ugt1a-deficient Wistar (Gunn) rats were fed a control diet or diet containing pregnenolone-16α-carbonitrile (PCN; 800 ppm), 3-methylcholanthrene (3-MC; 200 ppm), or Aroclor 1254 (PCB; 100 ppm) for 7 days. Serum T(4), triiodothyronine (T(3)), and TSH concentrations, hepatic T(4)/T(3) glucuronidation, and thyroid histology and follicular cell proliferation were investigated. PCN, 3-MC, and PCB treatments decreased serum T(4), whereas serum T(3) was maintained in both Gunn and Wistar rats (except for PCB treatment). TSH was increased in Wistar and Gunn rats after PCN (130 and 277%) or PCB treatment (72 and 60%). T(4) glucuronidation in Wistar rats was increased after PCN (298%), 3-MC (85%), and PCB (450%), but was extremely low in Gunn rats, and unchanged after MEI. T(3) glucuronidation was increased after PCN (121%) or PCB (58%) in Wistar rats, but only PCN increased T(3) glucuronidation in Gunn rats (43%). PCN treatment induced thyroid morphological changes and increased follicular cell proliferation in both strains. These data demonstrate that T(4) glucuronidation cannot be increased in Ugt1a-deficient Gunn rats. Thus, the decrease in serum T(4), increase in TSH, and increase in thyroid cell proliferation after MEI are not dependent on increased T(4) glucuronidation, and cannot be attributed to Ugt1a enzymes. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655938      PMCID: PMC3192499          DOI: 10.1016/j.taap.2010.07.010

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  35 in total

1.  Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues.

Authors:  A Hood; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2000-03-15       Impact factor: 4.219

2.  Decrease in serum thyroxine level by phenobarbital in rats is not necessarily dependent on increase in hepatic UDP-glucuronosyltransferase.

Authors:  Yoshihisa Kato; Hiroshi Suzuki; Shinichi Ikushiro; Shizuo Yamada; Masakuni Degawa
Journal:  Drug Metab Dispos       Date:  2005-07-27       Impact factor: 3.922

3.  The effect of phenobarbital on the metabolism and excretion of thyroxine in rats.

Authors:  R M McClain; A A Levin; R Posch; J C Downing
Journal:  Toxicol Appl Pharmacol       Date:  1989-06-15       Impact factor: 4.219

Review 4.  Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism.

Authors:  C D Klaassen; A M Hood
Journal:  Toxicol Pathol       Date:  2001 Jan-Feb       Impact factor: 1.902

5.  Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy.

Authors:  A Hood; R Hashmi; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1999-10-15       Impact factor: 4.219

6.  Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.

Authors:  Lloyd Lecureux; Matthew Z Dieter; David M Nelson; Linda Watson; Harvey Wong; Brian Gemzik; Curtis D Klaassen; Lois D Lehman-McKeeman
Journal:  Toxicol Sci       Date:  2009-02-11       Impact factor: 4.849

Review 7.  Thyroid gland neoplasia: non-genotoxic mechanisms.

Authors:  R M McClain
Journal:  Toxicol Lett       Date:  1992-12       Impact factor: 4.372

8.  Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex.

Authors:  Y Emi; S Ikushiro; T Iyanagi
Journal:  J Biochem       Date:  1995-02       Impact factor: 3.387

9.  Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans.

Authors:  Yoshihisa Kato; Shin-ichi Ikushiro; Yoshikazu Emi; Sekihiro Tamaki; Hiroshi Suzuki; Toshiyuki Sakaki; Shizuo Yamada; Masakuni Degawa
Journal:  Drug Metab Dispos       Date:  2007-10-01       Impact factor: 3.922

10.  A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine level in rats.

Authors:  Yoshihisa Kato; Shin-ichi Ikushiro; Rie Takiguchi; Koichi Haraguchi; Nobuyuki Koga; Shinya Uchida; Toshiyuki Sakaki; Shizuo Yamada; Jun Kanno; Masakuni Degawa
Journal:  Drug Metab Dispos       Date:  2007-07-16       Impact factor: 3.922

View more
  2 in total

1.  Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action.

Authors:  Katie B Paul; Joan M Hedge; Ruby Bansal; R Thomas Zoeller; Robert Peter; Michael J DeVito; Kevin M Crofton
Journal:  Toxicology       Date:  2012-06-01       Impact factor: 4.221

2.  Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS).

Authors:  Louise Ramhøj; Ulla Hass; Mary E Gilbert; Carmen Wood; Terje Svingen; Diana Usai; Anne Marie Vinggaard; Karen Mandrup; Marta Axelstad
Journal:  Sci Rep       Date:  2020-02-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.